Masimo stock has experienced upward momentum and positive market revaluations driven by several key corporate catalysts, including strong quarterly financial results that beat Wall Street revenue expectations, successful healthcare sector expansions, and major victories in high-stakes patent infringement lawsuits against large technology companies. Additionally, announcements regarding major corporate acquisition interest and robust demand for its core medical monitoring devices have heavily boosted investor confidence.